Carbidopa (KAISER FOUNDATION HOSPITALS)


Welcome to the PulseAid listing for the Carbidopa drug offered from KAISER FOUNDATION HOSPITALS. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: KAISER FOUNDATION HOSPITALS
NON-PROPRIETARY NAME: Carbidopa Tablets
SUBSTANCE NAME: CARBIDOPA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2017-02-14
END MARKETING DATE: 0000-00-00


Carbidopa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCarbidopa from KAISER FOUNDATION HOSPITALS
LABELER NAME: KAISER FOUNDATION HOSPITALS
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/1)
START MARKETING DATE: 2017-02-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0179-0226_da976778-fca5-43c4-b890-c5aa75d906d9
PRODUCT NDC: 0179-0226
APPLICATION NUMBER: NDA017830

Other CARBIDOPA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Carbidopa Tablets, 25 mg
Amerigen Pharmaceuticals Inc.Carbidopa
Aton Pharma, IncLodosyn
Avera McKennan HospitalLodosyn
Edenbridge Pharmaceuticals LLCCarbidopa
Ingenus Pharmaceuticals NJ, LLCCARBIDOPA
KAISER FOUNDATION HOSPITALSLODOSYN
Oceanside PharmaceuticalsCarbidopa